A State of Healing at Every Stage of Life
Canurta focuses on the groundbreaking exploration of novel polyphenolic molecules. We're broadening the understanding of their therapeutic potential through ongoing safety and efficacy trials to create new possibilities for standards of care.
Our team connects the dots across research completed over the course of many decades on polyphenols, Cannflavins and related flavonoids and stilbenes, reimagining approaches to natural ingredient efficacy and biopharmaceutical development.
Backed By Research
Our story began in 2019 with University of Guelph researcher Tariq Akhtar, PhD, after he and his team discovered how to efficiently extract and enrich the important anti-inflammatory polyphenols unique to hemp.
Canurta also works with Dr. Ethan Russo, MD, a board-certified neurologist and psychopharmacology researcher who is the preeminent global medical cannabis expert.
As our Senior Medical Advisor, Dr. Russo will lead the way for biotech development with top researchers and institutions.
Canurta’s White Paper
We're Committed to Sustainable Production Practices
From farm to market, sustainability is a cornerstone of everything we do. Canurta is proactive about seeking out partners who demonstrate leadership in corporate sustainability and strive to move beyond minimum standards.
Canurta practices zero-waste manufacturing with extraction technology designed to repurpose waste biomass in addition to allowing for recyclability of key inputs.
Our Ecosystem Partners
Meet Our Founder and CEO
Akeem Gardner believes that hemp is a real catalyst for change. He started growing hemp 5 years ago with a mission to discover meaningful ways to disrupt industries that impact our wellbeing the most.
He’s on a path to launch real, natural solutions for inflammation to solve the world’s biggest health challenge – preventing and managing chronic disease effectively and safely.
Board of Directors
Angel investor and board member, Manitoba Harvest and Fresh Hemp Foods
Led first Canadian company to commercialize industrial hemp to $132.5M exit
Co-Founder, Manitoba Harvest
Created Canadian market for hemp hearts
Manitoba Harvest first sale of $132.5 Million
Founder, Organic Traditions
and President, Advantage Health Matters
30+ years experience in
Portfolio of over 100
Scientific Advisory Board
Dr. Ethan Russo, M.D.
Senior Medical Advisor
Preeminent global medical cannabis expert
16 years at GW Pharmaceuticals
Study Physician for Sativex® and Epidiolex® clinical trials
Dr. Neal Davis, Ph.D., RPh
Principal Investigator, Pharmacokinetics
Dean and Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta
Leading investigator of anti-inflammatory/
anti-cancer nutraceuticals including flavonoids
Jasmin Lalonde, Ph.D.
Principal Investigator, Neuroscience
Department of Molecular Cellular Neurology,
University of Guelph
2020 Future Leader in Canadian Brain Research
José Casaretto, Ph.D.
Senior Technical Advisor
Research Scientist focused on genomics and biochemical engineering approaches to produce secondary metabolites
Inventor on extraction and biosynthesis patents
Tariq Akhtar, Ph.D.
Principal Investigator, Molecule Development
Department of Molecular Biology Associate Professor, University of Guelph
Research focus on natural products and specialized metabolites
Mark Loveless, M.D.
Senior Medical Epidemiologist, Director of the HIV/STD/TB Program of the Oregon Health Unity
Consultant for COVID-19 response with public health agencies in Pacific Northwest